1
|
Ning J, Wang W, Ge G, Chu P, Long F, Yang Y, Peng Y, Feng L, Ma X, James TD. Target Enzyme-Activated Two-Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two-Dimensional Design Strategy. Angew Chem Int Ed Engl 2019; 58:9959-9963. [PMID: 31099941 DOI: 10.1002/anie.201903683] [Citation(s) in RCA: 63] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2019] [Revised: 04/24/2019] [Indexed: 01/08/2023]
Abstract
The rapid development of fluorescent probes for monitoring target enzymes is still a great challenge owing to the lack of efficient ways to optimize a specific fluorophore. Herein, a practical two-dimensional strategy was designed for the development of an isoform-specific probe for CYP3A4, a key cytochrome P450 isoform responsible for the oxidation of most clinical drugs. In first dimension of the design strategy, a potential two-photon fluorescent substrate (NN) for CYP3A4 was effectively selected using ensemble-based virtual screening. In the second dimension, various substituent groups were introduced into NN to optimize the isoform-selectivity and reactivity. Finally, with ideal selectivity and sensitivity, NEN was successfully applied to the real-time detection of CYP3A4 in living cells and zebrafish. These findings suggested that our strategy is practical for developing an isoform-specific probe for a target enzyme.
Collapse
Affiliation(s)
- Jing Ning
- College of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, College of Pharmacy, Dalian Medical University, Dalian, 116044, China
| | - Wei Wang
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China
| | - Guangbo Ge
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Peng Chu
- College of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.,Center for Molecular Medicine, School of Life Science and Biotechnology, State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China
| | - Feida Long
- Center for Molecular Medicine, School of Life Science and Biotechnology, State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China
| | - Yongliang Yang
- Center for Molecular Medicine, School of Life Science and Biotechnology, State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China
| | - Yulin Peng
- College of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, College of Pharmacy, Dalian Medical University, Dalian, 116044, China
| | - Lei Feng
- College of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.,Center for Molecular Medicine, School of Life Science and Biotechnology, State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China
| | - Xiaochi Ma
- College of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.,Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China
| | - Tony D James
- Department of Chemistry, University of Bath, Bath, BA2 7AY, UK
| |
Collapse
|
2
|
Ning J, Wang W, Ge G, Chu P, Long F, Yang Y, Peng Y, Feng L, Ma X, James TD. Target Enzyme‐Activated Two‐Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two‐Dimensional Design Strategy. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201903683] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Jing Ning
- College of Integrative MedicineThe National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative DiseaseCollege of PharmacyDalian Medical University Dalian 116044 China
| | - Wei Wang
- School of PharmacyHunan University of Chinese Medicine Changsha 410208 China
| | - Guangbo Ge
- Institute of Interdisciplinary Integrative Medicine ResearchShanghai University of Traditional Chinese Medicine Shanghai 201203 China
| | - Peng Chu
- College of Integrative MedicineThe National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative DiseaseCollege of PharmacyDalian Medical University Dalian 116044 China
- Center for Molecular Medicine, School of Life Science and BiotechnologyState Key Laboratory of Fine ChemicalsDalian University of Technology Dalian 116024 China
| | - Feida Long
- Center for Molecular Medicine, School of Life Science and BiotechnologyState Key Laboratory of Fine ChemicalsDalian University of Technology Dalian 116024 China
| | - Yongliang Yang
- Center for Molecular Medicine, School of Life Science and BiotechnologyState Key Laboratory of Fine ChemicalsDalian University of Technology Dalian 116024 China
| | - Yulin Peng
- College of Integrative MedicineThe National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative DiseaseCollege of PharmacyDalian Medical University Dalian 116044 China
| | - Lei Feng
- College of Integrative MedicineThe National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative DiseaseCollege of PharmacyDalian Medical University Dalian 116044 China
- Center for Molecular Medicine, School of Life Science and BiotechnologyState Key Laboratory of Fine ChemicalsDalian University of Technology Dalian 116024 China
| | - Xiaochi Ma
- College of Integrative MedicineThe National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative DiseaseCollege of PharmacyDalian Medical University Dalian 116044 China
- Jiangsu Key Laboratory of New Drug Research and Clinical PharmacyXuzhou Medical University Xuzhou 221004 China
| | - Tony D. James
- Department of ChemistryUniversity of Bath Bath BA2 7AY UK
| |
Collapse
|
3
|
Rioux N, Bellavance E, Bourg S, Garneau M, Ribadeneira MD, Duan J. Assessment of CYP3A-mediated drug-drug interaction potential for victim drugs using an in vivo rat model. Biopharm Drug Dispos 2013; 34:396-401. [PMID: 23873286 DOI: 10.1002/bdd.1855] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2013] [Revised: 06/25/2013] [Accepted: 07/16/2013] [Indexed: 12/12/2022]
Abstract
The present study aims to determine if an in vivo rat model of drug-drug interaction (DDI) could be useful to discriminate a sensitive (buspirone) from a 'non-sensitive' (verapamil) CYP3A substrate, using ketoconazole and ritonavir as perpetrator drugs. Prior to in vivo studies, ketoconazole and ritonavir were shown to inhibit midazolam hydroxylation with IC50 values of 350 ± 60 nm and 11 ± 3 nm, respectively, in rat liver microsomes (RLM). Buspirone and verapamil were also shown to be substrates of recombinant rat CYP3A1/3A2. In the rat model, the mean plasma AUC0-inf of buspirone (10 mg/kg, p.o.) was increased by 7.4-fold and 12.8-fold after co-administration with ketoconazole and ritonavir (20 mg/kg, p.o.), respectively. The mean plasma AUC0-inf of verapamil (10 mg/kg, p.o.) was increased by 3.0-fold and 4.8-fold after co-administration with ketoconazole and ritonavir (20 mg/kg, p.o.), respectively. Thus, the rat DDI model correctly identified buspirone as a sensitive CYP3A substrate (>5-fold AUC change) in contrast to verapamil. In addition, for both victim drugs, the extent of DDI when co-administered was greater with ritonavir compared with ketoconazole, in line with their in vitro CYP3A inhibition potency in RLM. In conclusion, our study extended the rat DDI model applicability to two additional victim/perpetrator pairs. In addition, we suggest that use of this model would increase our confidence in estimation of the DDI potential for victim drugs in early discovery.
Collapse
Affiliation(s)
- Nathalie Rioux
- Biological Sciences, Boehringer-Ingelheim (Canada) Ltd, 2100 Cunard Street, Laval, Québec, Canada, H7S 2G5
| | | | | | | | | | | |
Collapse
|
4
|
Müller AC, Kanfer I. Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines. Biopharm Drug Dispos 2012; 32:458-70. [PMID: 22024968 DOI: 10.1002/bdd.775] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The use of traditional/complementary/alternate medicines (TCAMs) in HIV/AIDS patients who reside in Southern Africa is quite common. Those who use TCAMs in addition to antiretroviral (ARV) treatment may be at risk of experiencing clinically significant pharmacokinetic (PK) interactions, particularly between the TCAMs and the protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). Mechanisms of PK interactions include alterations to the normal functioning of drug efflux transporters, such as P-gp and/or CYP isoenzymes, such a CYP3A4 that mediate the absorption and elimination of drugs in the small intestine and liver. Specific mechanisms include inhibition and activation of these proteins and induction via the pregnane X receptor (PXR). Several clinical studies and case reports involving ARV-herb PK interactions have been reported. St John's Wort, Garlic and Cat's Claw exhibited potentially significant interactions, each with a PI or NNRTI. The potential for these herbs to induce PK interactions with drugs was first identified in reports of in vitro studies. Other in vitro studies have shown that several African traditional medicinal (ATM) plants and extracts may also demonstrate PK interactions with ARVs, through effects on CYP3A4, P-gp and PXR. The most complex effects were exhibited by Hypoxis hemerocallidea, Sutherlandia frutescens, Cyphostemma hildebrandtii, Acacia nilotica, Agauria salicifolia and Elaeodendron buchananii. Despite a high incidence of HIV/AIDs in the African region, only one clinical study, between efavirenz and Hypoxis hemerocallidea has been conducted. However, several issues/concerns still remain to be addressed and thus more studies on ATMs are warranted in order for more meaningful data to be generated and the true potential for such interactions to be determined.
Collapse
Affiliation(s)
- Adrienne C Müller
- Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, Grahamstown, 6140, South Africa
| | | |
Collapse
|